Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.
about
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young childrenRibavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young childrenInhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadChallenges and opportunities in developing respiratory syncytial virus therapeuticsRespiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentManagement of acute bronchiolitisRSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?Animal pneumoviruses: molecular genetics and pathogenesis.Diagnosis and treatment of viral infections.Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezingEnvironmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections.Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.Pediatric infections.Antiviral therapy: current concepts and practicesDetection, pathogenesis, and therapy of respiratory syncytial virus infectionsTime-resolved fluoroimmunoassay compared with virus isolation for rapid detection of respiratory syncytial virus in nasopharyngeal aspiratesComparison of enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and virus isolation for detection of respiratory viruses in nasopharyngeal secretions.Acute bronchiolitis in infancy: treatment and prognosisBiochemistry and clinical applications of ribavirin.Detection of respiratory syncytial virus A and B and parainfluenzavirus 3 sequences in respiratory tracts of infants by a single PCR with primers targeted to the L-polymerase gene and differential hybridizationRibavirin and acute bronchiolitis in infancy.Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR.Comparison of HEp-2 cell culture and Abbott respiratory syncytial virus enzyme immunoassay.Comparison of three rapid diagnostic techniques for detection of respiratory syncytial virus from nasal wash specimens.Diagnostic efficacy of two rapid tests for detection of respiratory syncytial virus antigen.Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay.Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies.The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, versus its achievable concentrations in the human respiratory tract and comparison to ribavirin.Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report.An outbreak of an influenza-like illness in a nursing home.Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat.Fatal respiratory syncytial virus pneumonitis in a previously healthy child.Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo.Severity of illness models for respiratory syncytial virus-associated hospitalization.Atypical extrapulmonary presentations of severe respiratory syncytial virus infection requiring intensive care.Severe respiratory syncytial virus pneumonia in an adult renal transplant recipient: successful treatment with ribavirin.
P2860
Q24235515-E32B0F0E-145E-4668-887A-31F86B4A45CFQ24242993-D931F18F-E305-4ADF-96E7-0BCDDB676B05Q26822988-B85AAB69-ECB1-40FC-B93F-8296DCC6E0AFQ30300567-F869D260-C249-471C-894F-B3513126BE81Q33588916-9FBEF499-F957-4BE2-B285-7F89598D3D8DQ33625250-A2C588A2-FB58-4388-98D1-BCCE02553D01Q33802570-FF04E00B-4F16-4A26-9D2F-A34990954A30Q34313560-E0F4E1EE-50C5-4C97-8A1A-DAF33A45971AQ35119839-54632109-69F4-4103-8204-E244DCD869A7Q35252795-8694B121-C894-4F18-8AC2-8B0AE2D4291BQ35257419-F4EBC0C8-9CA4-4CCC-AA4C-5C51BD429F53Q35262745-B1571FCF-F394-41CD-B07D-A6EE6B4E01F3Q35540919-B862FC0D-87A6-4624-B331-B082F3328DC8Q35562475-1415C41E-92C7-440A-9C23-87679D99C507Q35893234-9C3C4DCA-8363-487E-9425-264D5C8A3AC0Q36070394-FFB0508F-3CF5-4429-9B99-280E33783248Q36632499-04CD0645-F364-413D-8295-E6EBF93348D5Q37159449-6BA104D8-18EE-4939-B2A7-4E87D0C86975Q37231528-3379EEC8-D747-409B-B807-AD713AC1B181Q38612558-CA8F660B-49AC-4C70-AA42-6D608D1452DBQ39460438-7277ABBF-B0F0-4380-B042-E9DE3E17C8AAQ39552717-F99592C6-1705-45B2-B6F8-CB4898F66070Q39607138-D5A0366F-94C8-4999-8D5E-8BF846603335Q39732911-49D2F61E-6DBB-45C7-8EA2-8224245C456FQ40189571-4EBACA13-3C2A-4635-9E24-CA53B0F2A1F2Q40190398-4FB6BC3A-4F99-41EC-8A17-FADE4C1303ABQ40190558-ED580ABC-4D3E-46AF-BD2F-31660D0A7789Q40191884-6421CB5D-9A47-4144-A874-DE3796938517Q40201478-2980B024-9CD1-481A-B260-B102464FEE9EQ41921750-C53E1748-FFAE-47D6-8C3E-F9AD5E02F2AFQ42134152-875FB8FF-94EB-4D7E-AAED-639A2FBAD225Q42262215-043B2582-0A18-4581-B84E-2C01190C4CE6Q42425870-D40FF4C6-E8DC-4EEE-BAD5-5BA152DA0F27Q43474495-2C5960D4-1F5E-4354-ADF5-BFC23776E952Q43872054-DC6825F4-6E11-46EE-8D35-6222DF680895Q43995764-A3852729-9955-471D-9C8D-12E558C7A8CAQ45748055-A4F1BD70-F00C-4070-B0DA-1A6017ACD617Q45750249-C444DABE-3C61-429F-BF99-1798A32C1EF1Q45774519-1A9D7DB7-9F77-4199-B615-7960892C6FAAQ45849362-DCCF41B0-FFE4-456E-91EB-A1750D5CFBE7
P2860
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@en
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@nl
type
label
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@en
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@nl
prefLabel
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@en
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@nl
P2093
P1476
Ribavirin treatment of respira ...... lying cardiopulmonary disease.
@en
P2093
J T McBride
K C Schnabel
S W Hildreth
P304
P356
10.1001/JAMA.1985.03360210063030
P407
P577
1985-12-01T00:00:00Z